At our core, we are scientists and pioneers in genome analysis, united by a belief that health can be understood, predicted, and transformed through systems-level insight.
We started the company with a clear focus: developing biomarkers of drug response using advanced omics technologies and mechanistic computer modeling. But as our work deepened and our expertise grew, so did our vision. We quickly recognized the need to build platforms capable of capturing the true complexity of biology.
Over the course of an extensive and impactful R&D journey, we built the foundation for what we offer today: systems-level multi-omics intelligence that combines certified NGS data generation, AI-powered bioinformatics, and modular tools that transform complex data into actionable insights.
Our company operates on a dual model—delivering accredited oncology diagnostic solutions and offering flexible NGS and bioinformatics services to support the full spectrum of precision health innovation
We have evolved into an ISO 15189-accredited clinical laboratory, delivering comprehensive molecular diagnostics for oncology. Our innovative Alacris-CMTA® molecular test as a service integrate genomic and whole transcriptomic data into clinically actionable reports, supporting precision treatment decisions. Our proprietary software platform enables clinicians and partners to analyse and interpret complex molecular data with clarity and confidence.
In parallel with our diagnostics offering, we support the research community, pharma and biotech innovators with advanced NGS services, custom multi-omics pipelines, and deep bioinformatics expertise—accelerating discovery in cancer biology, aging, and therapeutic development.
Looking ahead, we are expanding our services to include frontier technologies such as spatial transcriptomics, single-cell analysis, and NGS-based proteomics profiling. While these innovations are not yet diagnostic-grade, they are central to our R&D pipeline and will shape the next generation of systems-level diagnostics.
»We firmly believe in democratizing comprehensive omics—making multi-layered, high-resolution molecular data more accessible, interpretable, and impactful across both clinical and research domains.«
This is the heart of our vision: To bring omics for health into everyday care—unlocking new possibilities for prevention, longevity, and truly personalized medicine.
We’re building the future of precision health—where biology is decoded, care is proactive, and time becomes a sustainable, measurable asset.